Epigenetics and Nanomedicine

30 September 2026

The oxidative and carbonyl stress axis in anti-vascular endothelial growth factor-refractory neovascular age-related macular degeneration: Implications for therapeutic repurposing

Epigenetics and Nanomedicine, Publications

15 September 2026

Doing More with Less: Accurate and Scalable Ligand Free Energy Calculations by Focusing on the Binding Site

Epigenetics and Nanomedicine, Publications

19 August 2026

IMSignature-Implementation of in vitro molecular signatures to improve diagnosis and therapeutic strategies in rare diseases

Epigenetics and Nanomedicine

18 August 2026

ATLAS-Defining ALK2-Activin signaling axis in rare diseases

Epigenetics and Nanomedicine, Projects

14 July 2026

Epigenetic clocks as quantitative readouts of epigenetic drift

Epigenetics and Nanomedicine, Publications

18 June 2026

Scientists at the Sarcomas and Experimental Therapies Laboratory develop an effective nanotherapy for chemoresistant osteosarcomas

Epigenetics and Nanomedicine, News Nanomedicine